Free Trial
OTCMKTS:CPMV

Mosaic ImmunoEngineering (CPMV) Stock Price, News & Analysis

$0.60
0.00 (0.00%)
(As of 07/22/2024 ET)
Today's Range
$0.60
$0.60
50-Day Range
$0.29
$0.65
52-Week Range
$0.10
$1.00
Volume
8 shs
Average Volume
734 shs
Market Capitalization
$4.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CPMV stock logo

About Mosaic ImmunoEngineering Stock (OTCMKTS:CPMV)

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California.

CPMV Stock Price History

CPMV Stock News Headlines

Jeff Bezos Just Humiliated Elon Musk
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
Mosaic ImmunoEngineering Inc Ordinary Shares CPMV
Jeff Bezos Just Humiliated Elon Musk
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
The Mosaic Co MOS
CPMV Mosaic ImmunoEngineering Inc.
Mosaic Unusual Options Activity For March 15
Mosaic ImmunoEngineering Inc. (CPMV)
See More Headlines
Receive CPMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mosaic ImmunoEngineering and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/14/2024
Today
7/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
OTCMKTS:CPMV
Employees
3
Year Founded
N/A

Profitability

Net Income
$-1,010,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.81) per share

Miscellaneous

Free Float
1,377,000
Market Cap
$4.34 million
Optionable
Not Optionable
Beta
-0.02
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

Key Executives

  • Mr. Steven W. King (Age 60)
    Chairman of the Board, President & CEO
    Comp: $267.84k
  • Mr. Paul J. Lytle CPA (Age 56)
    Executive VP, CFO, Secretary & Director
    Comp: $295.53k
  • Jay Carlson
    Senior Manager of Investor Relations
  • Mr. Joseph S. Shan M.P.H. (Age 51)
    Head of Clinical Operations
  • Dr. Marvin R. Garovoy M.D. (Age 80)
    Head of Medical Immuno-Oncology
  • Cyril Empig Ph.D.
    Head of Vaccine Development

CPMV Stock Analysis - Frequently Asked Questions

How have CPMV shares performed this year?

Mosaic ImmunoEngineering's stock was trading at $0.60 on January 1st, 2024. Since then, CPMV stock has increased by 0.0% and is now trading at $0.60.
View the best growth stocks for 2024 here
.

How were Mosaic ImmunoEngineering's earnings last quarter?

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) announced its earnings results on Tuesday, May, 14th. The company reported ($0.04) earnings per share (EPS) for the quarter.

How do I buy shares of Mosaic ImmunoEngineering?

Shares of CPMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CPMV) was last updated on 7/23/2024 by MarketBeat.com Staff

From Our Partners